These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16604016)

  • 1. [Cellular signalling pathways and pathophysiology of pulmonary arterial hypertension].
    Dao P; Montani D; Duong-Quy S; Dinh-Xuan AT
    Rev Mal Respir; 2006 Feb; 23(1 Suppl):3S75-83. PubMed ID: 16604016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative feedback in NO/cGMP signalling.
    Koesling D; Mullershausen F; Lange A; Friebe A; Mergia E; Wagner C; Russwurm M
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1119-22. PubMed ID: 16246060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nitric oxide/cGMP signaling pathway in pulmonary hypertension.
    Klinger JR
    Clin Chest Med; 2007 Mar; 28(1):143-67, ix. PubMed ID: 17338933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
    Schermuly RT; Pullamsetti SS; Kwapiszewska G; Dumitrascu R; Tian X; Weissmann N; Ghofrani HA; Kaulen C; Dunkern T; Schudt C; Voswinckel R; Zhou J; Samidurai A; Klepetko W; Paddenberg R; Kummer W; Seeger W; Grimminger F
    Circulation; 2007 May; 115(17):2331-9. PubMed ID: 17438150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guanylate cyclases: physiological processes mediated by cyclic GMP].
    Rivero-Vilches F; de Frutos S; Rodríguez-Puyol M; Rodríguez-Puyol D; Saura M
    Nefrologia; 2001; 21(3):233-9. PubMed ID: 11471303
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension.
    Chen CN; Watson G; Zhao L
    Vascul Pharmacol; 2013 Mar; 58(3):211-8. PubMed ID: 22982057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nitric oxide and pulmonary hypertension].
    Nakamoto T; Harasawa H; Fuse D; Amano H; Matsuda T
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():522-6. PubMed ID: 15506441
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic nucleotides and phosphodiesterases in platelets.
    Haslam RJ; Dickinson NT; Jang EK
    Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732
    [No Abstract]   [Full Text] [Related]  

  • 9. Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells.
    Cawley SM; Sawyer CL; Brunelle KF; van der Vliet A; Dostmann WR
    Cell Signal; 2007 May; 19(5):1023-33. PubMed ID: 17207606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear signaling in smooth muscle cells: cyclic nucleotide phosphodiesterase 1A moves in.
    Bornfeldt KE
    Circ Res; 2006 Mar; 98(6):720-2. PubMed ID: 16574912
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferation.
    Koyama H; Bornfeldt KE; Fukumoto S; Nishizawa Y
    J Cell Physiol; 2001 Jan; 186(1):1-10. PubMed ID: 11147803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nitric Oxide Pathway in Pulmonary Vascular Disease.
    Klinger JR; Kadowitz PJ
    Am J Cardiol; 2017 Oct; 120(8S):S71-S79. PubMed ID: 29025573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin induces growth hormone secretion via a nitric oxide/cGMP signalling pathway.
    Rodríguez-Pacheco F; Luque RM; Tena-Sempere M; Malagón MM; Castaño JP
    J Neuroendocrinol; 2008 Mar; 20(3):406-12. PubMed ID: 18208548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens.
    Seftel AD
    J Urol; 2005 Sep; 174(3):1043. PubMed ID: 16094045
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxidative and nitrosative stress in pediatric pulmonary hypertension: roles of endothelin-1 and nitric oxide.
    Black SM; Fineman JR
    Vascul Pharmacol; 2006 Nov; 45(5):308-16. PubMed ID: 17049313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel concepts in the pathobiology of pulmonary arterial hypertension].
    Rosenkranz S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S167-9. PubMed ID: 18814087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study.
    Oelke M; Hedlund P; Albrecht K; Ellinghaus P; Stief CG; Jonas U; Andersson KE; Uckert S
    Urology; 2006 May; 67(5):1111-6. PubMed ID: 16635522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects.
    Werkström V; Svensson A; Andersson KE; Hedlund P
    BJU Int; 2006 Aug; 98(2):414-23. PubMed ID: 16626307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.